| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Pharmaceuticals
| Eli Lilly is making significant strides in product and service development, particularly in the realms of obesity and diabetes treatments, driven by a robust pipeline and innovative drugs. The company's recent approvals and success, especially with its GLP-1 drug and tirzepatide, highlight strong market reception and potential for future growth. Additionally, Eli Lilly's commitment to targeted therapies for complex health challenges reflects its dedication to advancing healthcare solutions. Overall, these factors position the company favorably within a rapidly evolving market landscape. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at -0.2 is modestly bearish. The market sentiment at 1.2 is very bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. There is no clear direction for LLY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 1.3, and the negative at -0.1 on 2026-09-18. The forces of Sector Price Trend (-0.4), and Stock Price Trend (-0.2) will drive down the price. The forces of Price Level Sentiment (0), Market Risk Appetite (0.5), Option Sentiment (0.8), Valuation Sentiment (2.4), and Sentiment towards Fundamentals (4.2) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| LLY | ||||||||||||||||
| Date | Attention | Price | StdDev | Price Level | RSI | Hourly RSI | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-18 | 0%(0.1%) | 1152.73 | 3.41% | 43 | 40 | 58 | 0.04% | -0.06% | -0.2 | 0.2 | 0.4% | 1.3 | Long | 55% | 4.2 | 6.3 |
| 2026-09-17 | 0%(0.1%) | 1152.25 | 3.74% | 41 | 39 | 62 | 1.18% | -0.07% | -0.5 | 0.3 | 0.4% | 0.6 | Wait | 50% | 3.8 | -1 |
| 2026-09-16 | 0%(0.1%) | 1138.8 | 4.34% | 32 | 26 | 44 | 0.16% | -0.18% | -0.5 | -0.1 | 0.4% | 0.5 | Short | 55% | 3.9 | -1 |
| 2026-09-15 | 1%(0.1%) | 1136.98 | 4.39% | 29 | 17 | 47 | -0.01% | -0.18% | -0.3 | -0.2 | 0.9% | 0.2 | Short | 55% | 3.3 | 6.8 |
| 2026-09-14 | 0%(0%) | 1137.15 | 4.31% | 28 | 16 | 64 | 1.97% | -0.32% | -0.6 | 0.1 | 1% | 0.2 | Wait | 50% | 1.7 | -1 |
| 2026-09-13 | 0%(0%) | -1.3 | 0.1 | -0.2 | 2 | -1 | ||||||||||
| 2026-09-12 | 0%(0%) | -1.3 | 0.1 | -0.2 | 1.9 | -1 | ||||||||||
| 2026-09-11 | 0%(0.1%) | 1115.23 | 4.3% | 15 | 2 | 37 | -0.67% | -0.52% | -1.3 | -0.2 | 0.3% | 0.1 | Short | 55% | 2.3 | -1 |
| 2026-09-10 | 0%(0.1%) | 1122.77 | 4.07% | 14 | 8 | 42 | -0.12% | -0.57% | -1.4 | -0.1 | 0.2% | -0 | Short | 55% | 1.3 | -1 |
| 2026-09-09 | 0%(0.1%) | 1124.16 | 3.88% | 11 | 7 | 46 | 0.05% | -0.94% | -1.6 | -0.2 | 0.9% | 0 | Short | 65% | 1.6 | -1 |
| Long is the preferred trading strategy with 55% chance of being right. Improving trend sentiment and positive hourly trend. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||||
| Analysis | ||
| ● Eli Lilly (LLY) – Equity Research Report Tue. Mar 17, 2026 | ||
| 2026-09-18 17:02:03 The introduction of targeted treatments for advanced breast cancer represents a significant step forward in Eli Lilly's commitment to addressing complex health challenges. |
| 2026-09-18 17:02:03 Comparative analysis with competitors, such as Costco, showcases Eli Lilly's unique advantages and potential for cautious investors. |
| 2026-09-18 17:02:03 The stock performance of Eli Lilly, while showing modest daily changes, reflects a strong overall market position boosted by successful product launches. |
| 2026-09-18 17:02:03 Eli Lilly's portfolio of innovative drugs, especially in the weight loss segment, indicates strong market growth potential and attracts cautious investors. |
| 2026-09-18 17:02:03 Recent FDA approvals for Eli Lilly's breast cancer drug combination highlight significant regulatory advancements, positively impacting the company's product offerings. |
| 2026-09-18 13:47:49 The article notes improving trends in the diabetes market, suggesting a favorable industry environment for Eli Lilly's products. |
| 2026-09-18 13:47:49 The article discusses a positive outlook from analysts, raising price targets based on strong performance, which reflects confidence in the company's trajectory. |
| 2026-09-18 13:47:49 The article highlights the strong performance of Eli Lilly's diabetes drug, tirzepatide, indicating positive market reception and effectiveness. |
| 2026-09-18 11:48:06 The notion that certain companies can maintain performance regardless of market fluctuations suggests a trend toward resilience in the industry. |
| 2026-09-18 11:48:06 The theme reflects the potential for stable investment returns in companies like Eli Lilly and Costco across various market conditions. |
| 2026-09-18 09:34:08 The approval and success of Eli Lilly's GLP-1 drug, showcasing innovation in healthcare products. |
| 2026-09-18 09:34:08 The surge in Eli Lilly's market value, positioning it as the world's most valuable pharmaceutical company. |
| 2026-09-18 09:34:08 Eli Lilly's significant increase in stock value, indicating strong performance in the market. |